Pharmaceutical Commerce - October 2022

Betting the House on Orphan Drugs

October 07, 2022



While all drug development efforts are fraught with peril, a growing number of biopharma companies—large and small—are staking a claim in the rare disease treatment space, chasing odds that could yield clinical and financial rewards